NIAID awards more than $12 million for the development of antiviral therapies

By | November 21, 2022
The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, recently awarded more than $12 million to three institutions for the development of antiviral therapies to treat diseases caused by viruses with pandemic potential.